ECO 2026: GLP-1-Based Obesity Therapy Reduced Fat More Than Muscle Mass Tags GLP-1 agonists Read more about ECO 2026: GLP-1-Based Obesity Therapy Reduced Fat More Than Muscle Mass
ECO 2026: Semaglutide Reduced BMI in Severe Youth Obesity Tags GLP-1 agonists Read more about ECO 2026: Semaglutide Reduced BMI in Severe Youth Obesity
ECO2026: Continued Tirzepatide Therapy Preserves Weight Loss Tags GLP-1 agonists Read more about ECO2026: Continued Tirzepatide Therapy Preserves Weight Loss
ECO 2026: Oral Orforglipron Maintains Weight Loss After GLP-1 Switch Tags GLP-1 agonists Read more about ECO 2026: Oral Orforglipron Maintains Weight Loss After GLP-1 Switch
ECO 2026: EASO Updates Obesity Drug Guidance Algorithm Tags GLP-1 agonists Read more about ECO 2026: EASO Updates Obesity Drug Guidance Algorithm
Combined FGF-21 and GDF-15 Testing Improves Insulin Resistance Detection Read more about Combined FGF-21 and GDF-15 Testing Improves Insulin Resistance Detection
Early Data Suggest PASI Improvement With GLP-1 RAs in Psoriasis Tags GLP-1 agonists Read more about Early Data Suggest PASI Improvement With GLP-1 RAs in Psoriasis
Does hs-CRP and Metabolic Syndrome Refine CAD Risk in T1DM? Tags CRP Diabetic Nephropathy Coronary artery disease Albuminuria Read more about Does hs-CRP and Metabolic Syndrome Refine CAD Risk in T1DM?
Brief Intermittent Activity Shows Lower T2DM Risk Tags Urban living Read more about Brief Intermittent Activity Shows Lower T2DM Risk
FIB-4 Index Identifies Residual CKD Risk in T2DM and Hypertension Read more about FIB-4 Index Identifies Residual CKD Risk in T2DM and Hypertension